1. Abhold RH, Sullivan MJ, Wright JW, Harding JW (1987) Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin. J Pharmacol Exp Ther 242:957–962
2. Antonyak MA, Kenyon LC, Godwin AK, James DC, Emlet DR, Okamoto I, Tnani M, Holgado-Madruga M, Moscatello DK, Wong AJ (2002) Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene 21:5038–5046
3. Bader M, Peters J, Baltatu O, Muller DN, Luft FC, Ganten D (2001) Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79:76–102
4. Blair-West JR, Carey KD, Denton DA, Madden LJ, Weisinger RS, Shade RE (2001) Possible contribution of brain angiotensin III to ingestive behaviors in baboons. Am J Physiol 281:R1633–R1636
5. Blume A, Undeutsch C, Zhao Y, Kaschina E, Culman J, Unger T (2005) ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain. Am J Physiol 289:R845–R850